Clinical Trial Update: Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of NNC-0156-0000-0009 during surgical procedures in people with Haemophilia B has completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Bleeding Disorder
• Haemophilia

Drugs mentioned

• NNC-0156-0000-0009

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia B | Phase 3 | Status: COMPLETED | Results posted: 2017-07-24